Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model

International Journal of Antimicrobial Agents

Volumn 31, Issue SUPPL. 1, 2008, Pages 102-107

  Han, Chang Hee ^a   Yang, Cho Hwan ^a   Sohn, Dong Wahn ^a   Kim, Sae Woong ^a   Kang, Sung Hak ^a   Cho, Yong Hyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antibiotics; Chronic bacterial prostatitis; Lycopene; Rat

Indexed keywords

CIPROFLOXACIN; CYCIN; LYCOPENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CHRONIC PROSTATITIS; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOMATO; URINE CULTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAROTENOIDS; CIPROFLOXACIN; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; ESCHERICHIA COLI INFECTIONS; MALE; PROSTATE; PROSTATITIS; RATS; RATS, WISTAR; URINE;

EID: 38149005602     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.07.016     Document Type: Article

References (21)

1. Pfau A., and Prostatitis. A continuing enigma. Urol Clin North Am 13 (1986) 695-715
2. Nickel J.C., Olson M.E., and Coseron J.W. Rat model of experimental bacterial prostatitis. Infection 19 Suppl. (1991) 126-130
3. Nickel J.C. Antibiotics for bacterial prostatitis. J Urol 163 (2000) 1407
4. Bjerklund Johansen T.E., Grunberg R.N., Guibert J., et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 34 (1998) 457-466
5. Ansari M.S., and Ansari S. Lycopene and prostate cancer. Future Oncol 1 (2005) 425-430
6. Wane D., and Lengacher C.A. Integrative review of lycopene and breast cancer. Oncol Nurs Forum 33 (2006) 127-137
7. Hsiao G., Wang Y., Tzu N.H., et al. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. J Lab Clin Med 146 (2005) 216-226
8. Werz K., Siler U., and Goralczyk R. Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430 (2004) 127-134
9. Lee Y.S., Shin M.S., and Cho Y.H. Experimental animal model of bacterial prostatitis. Korean J Urol 42 (2001) 636-641
10. Seo S.I., Lee S.J., Kim J.C., et al. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol 10 (2003) 485-491
11. Nickel J.C., Olson M.E., Barabas A., Benediktsson H., Dasgupta M.K., and Costerton J.W. Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 66 (1990) 47-54
12. Cho Y.H., Lee S.J., Lee J.Y., et al. Antibacterial effect of intraprostatic zinc injection in a rat model of chronic bacterial prostatitis. Int J Antimicrob Agents 19 (2002) 576-582
13. Terai A., Yamamoto S., Mitsumori K., et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol 4 (1997) 289-294
14. McNaughton-Collins M., Stafford R.S., O'Leary M.P., et al. How common is prostatitis? A national survey of physician visits. J Urol 159 (1998) 1224-1228
15. Winningham D.G., Nemoy N.J., and Stamey T.A. Diffusion of antibiotics from plasma into prostatic fluid. Nature 219 (1968) 139-143
16. Stamey T.A., Meares Jr. E.M., and Winningham D.G. Chronic bacterial prostatitis and diffusion of drugs into prostatic fluid. J Urol 103 (1970) 187-194
17. Di Mascio P., Kaiser S., and Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274 (1989) 532-538
18. Zhou J.F., Xiao W.Q., Zheng Y.C., et al. Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis. Asian J Androl 8 (2006) 317-323
19. Shahed A.R., and Shoskes D.A. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome. J Androl 21 (2000) 669-675
20. Herzog A., Siler U., Spitzer N., et al. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J 19 (2005) 272-274
21. Naber K.G., Sorgel F., Kees F., et al. Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration. Am J Med 87 (1989) 57S-59S